Galmed Pharmaceuticals | 20-F: Registration statement / Annual report / Transition report
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(9.9%),Heights Capital Management, Inc.(9.9%)
Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.
Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Allen Baharaff(6.2%),G. Yarom Medical Research Ltd.(4.5%)
Galmed Pharmaceuticals | EFFECT: Others
Galmed Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Galmed Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-CVI Investments, Inc.(9.9%),Heights Capital Management, Inc.(9.9%)
No Data